PLUS THERAPEUTICS, INC. — Director's Dealing 2011

Sep 15, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTORI THERAPEUTICS, INC. (CYTX)
CIK: 0001095981
Period of Report: 2011-09-14

Reporting Person: HAWRAN PAUL W (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-09-14	Common Stock	P	3000	$3.176	Acquired	69610	Direct
2011-09-14	Common Stock	P	2000	$3.232	Acquired	71610	Direct